Across Canada, healthcare practitioners are carefully adjusting their methods to BZD prescribing following the publication of recent guidelines. These recommendations aim to minimize the potential harms associated with long-term use and addiction, stressing the necessity of detailed patient reviews and exploring non-pharmacological management optio